Nanotechnology is a new concept that will soon become the pinnacle of science and technology. It penetrates using nanometer-sized molecules and has demonstrated its worth in space, medicine, and other fields of science. Because the eye is a small organ that can be easily accessed due to its exposed location, it is an ideal target for nanotechnology. It appears that the "discovery of nanomedicines has reawakened huge aspirations for ophthalmic pharmacotherapy, in which nanostructured drugs are predicted to pass through the eye's limiting barriers." Safe manufacturing procedures and unforeseen biological repercussions of nanomaterial use remain barriers to nanotechnology adoption. These challenges are not insurmountable, and this developing sector is likely to yield innovative treatments for ocular disorders.
Title : Coenzyme Q10 for the protection of lacrimal gland against high-dose radioiodine therapy associated oxidative damage: histopathologic and tissue cytokine level assessments in an animal model
Nihat Yumusak, Department of Pathology, Turkey
Title : Glaucoma tubes and their blebs. A personal reflection on the south african connection to the development of glaucoma tube shunts and their blebs
Jeffrey Freedman, Emeritus at State University of New York, United States
Title : (Un)avoidable errors in biometry and some ideas how to overcome them
Sibylle Scholtz, Institute of Experimental Ophthalmology, Germany
Title : A comparative assessment of dry eye disease among the farmers and office going people
Jyoti Bala Pandre , Aurobindo Nethralaya, India
Title : Rare and interesting case of choroidal melanoma presenting as a case of a congestive glaucoma left eye in a 55 years old male patient
Gowhar Ahmad, Florence Hospital multi-speciality center chanapora Srinagar Kashmir, India
Title : To evaluate the safety and efficacy of half fluence photodynamic therapy for symptomatic peripapillary circumscribed choroidal hemangiomas (CCHS)
Prabhjot Singh, Armed Forces Medical College, India